Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing "off the shelf" allogeneic cell therapies for serious medical conditions, today announced that Brian M. Culley, ...
Restoring SNAP23 or replenishing these vesicles shows promise for improving bone health in SMA. Weak bones in people with ...
SMA Europe is accepting proposals for research projects, with motor regeneration and SMA metabolism among the priority areas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results